Home > Insider Trading > Filing (0001127602-22-028088)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1830214	Ginkgo Bioworks Holdings Inc.	DNA	Biological Products, (No Disgnostic Substances) (2836)	872652913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1882756	Barry Canton	C/O Ginkgo Bioworks Holdings 27 Drydock Avenue Boston MA 02210		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2022-12-19	206,449	$1.67	18,802,382	No	4	S	Direct
Class A Common Stock	Disposition	2022-12-19	206,448	$1.67	18,802,386	No	4	S	Indirect	By Spouse
Class A Common Stock	Disposition	2022-12-20	408,767	$1.66	18,393,615	No	4	S	Direct
Class A Common Stock	Disposition	2022-12-20	408,767	$1.66	18,393,619	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Spouse
No	4	S	Direct
No	4	S	Indirect	By Spouse

Footnotes

Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a "sell to cover" transaction.